Humanwell Healthcare Group Co Ltd (600079) - Total Assets

Latest as of June 2025: CN¥37.56 Billion CNY ≈ $5.50 Billion USD

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) holds total assets worth CN¥37.56 Billion CNY (≈ $5.50 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 600079 net asset value for net asset value and shareholders' equity analysis.

Humanwell Healthcare Group Co Ltd - Total Assets Trend (2000–2024)

This chart illustrates how Humanwell Healthcare Group Co Ltd's total assets have evolved over time, based on quarterly financial data.

Humanwell Healthcare Group Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Humanwell Healthcare Group Co Ltd's total assets of CN¥37.56 Billion consist of 54.4% current assets and 45.6% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	10.7%
Accounts Receivable	CN¥9.20 Billion	25.2%
Inventory	CN¥3.57 Billion	9.8%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥2.62 Billion	7.2%
Goodwill	CN¥729.15 Million	2.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Humanwell Healthcare Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Humanwell Healthcare Group Co Ltd.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Humanwell Healthcare Group Co Ltd's current assets represent 54.4% of total assets in 2024, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 10.7% of total assets in 2024, down from 17.9% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 3.0% in 2000.
Asset Diversification: The largest asset category is accounts receivable at 25.2% of total assets.

Humanwell Healthcare Group Co Ltd Competitors by Total Assets

Key competitors of Humanwell Healthcare Group Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	China	CN¥21.15 Billion
Emcure Pharmaceuticals Ltd NSE:EMCURE	India	Rs93.93 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.75 Billion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr67.43 Billion
Changzhou Qianhong Biopharma Co Ltd SHE:002550	China	CN¥3.02 Billion

Humanwell Healthcare Group Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.54	1.50	1.24
Quick Ratio	1.29	1.21	0.99
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥7.28 Billion	CN¥6.68 Billion	CN¥3.21 Billion

Humanwell Healthcare Group Co Ltd - Advanced Valuation Insights

This section examines the relationship between Humanwell Healthcare Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.66
Latest Market Cap to Assets Ratio	0.12
Asset Growth Rate (YoY)	0.8%
Total Assets	CN¥36.51 Billion
Market Capitalization	$4.49 Billion USD

Valuation Analysis

Below Book Valuation: The market values Humanwell Healthcare Group Co Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Humanwell Healthcare Group Co Ltd's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Humanwell Healthcare Group Co Ltd (2000–2024)

The table below shows the annual total assets of Humanwell Healthcare Group Co Ltd from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	CN¥36.51 Billion ≈ $5.34 Billion	+0.84%
2023-12-31	CN¥36.20 Billion ≈ $5.30 Billion	+0.50%
2022-12-31	CN¥36.02 Billion ≈ $5.27 Billion	+4.41%
2021-12-31	CN¥34.50 Billion ≈ $5.05 Billion	+9.09%
2020-12-31	CN¥31.63 Billion ≈ $4.63 Billion	-9.67%
2019-12-31	CN¥35.01 Billion ≈ $5.12 Billion	-1.16%
2018-12-31	CN¥35.42 Billion ≈ $5.18 Billion	+0.05%
2017-12-31	CN¥35.41 Billion ≈ $5.18 Billion	+33.97%
2016-12-31	CN¥26.43 Billion ≈ $3.87 Billion	+45.59%
2015-12-31	CN¥18.15 Billion ≈ $2.66 Billion	+49.19%
2014-12-31	CN¥12.17 Billion ≈ $1.78 Billion	+25.34%
2013-12-31	CN¥9.71 Billion ≈ $1.42 Billion	+23.48%
2012-12-31	CN¥7.86 Billion ≈ $1.15 Billion	+27.40%
2011-12-31	CN¥6.17 Billion ≈ $902.92 Million	+45.93%
2010-12-31	CN¥4.23 Billion ≈ $618.73 Million	+27.82%
2009-12-31	CN¥3.31 Billion ≈ $484.07 Million	+29.51%
2008-12-31	CN¥2.55 Billion ≈ $373.77 Million	+5.67%
2007-12-31	CN¥2.42 Billion ≈ $353.70 Million	+5.05%
2006-12-31	CN¥2.30 Billion ≈ $336.68 Million	+12.51%
2005-12-31	CN¥2.04 Billion ≈ $299.24 Million	+12.06%
2004-12-31	CN¥1.82 Billion ≈ $267.02 Million	+8.22%
2003-12-31	CN¥1.69 Billion ≈ $246.75 Million	+18.17%
2002-12-31	CN¥1.43 Billion ≈ $208.81 Million	+43.96%
2001-12-31	CN¥991.27 Million ≈ $145.05 Million	+91.32%
2000-12-31	CN¥518.12 Million ≈ $75.82 Million	--

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic

Market Cap

$4.49 Billion

CN¥30.67 Billion CNY

Market Cap Rank

#3886 Global

#645 in China

Share Price

CN¥18.79

Change (1 day)

-0.48%

52-Week Range

CN¥17.24 - CN¥23.03

All Time High

CN¥37.30